Wescadia Group (http://wescadiagroup.com/about/), a healthcare consultancy firm, announces the release of its white paper “Pursuing Growth: Optimizing Business Development Opportunities”.

Although healthcare organizations are surrounded by opportunities to grow their revenue and/or net profit, unfortunately many of these opportunities will not be executed due to the high attrition rate associated with the business development process. Having a systematic business development process ensures that an organization identifies obscure opportunities, considers ways to “unlock” value from an opportunity, develops strategies to overcome a high attrition rate of ideas, and has an objective system to decide which opportunities to pursue.

The white paper describes seven ways to optimize the business development process so that healthcare companies can maximize the value from their ideas or opportunities. The seven ways include the following:

1. Communicate to stakeholders in the business development process about the high attrition rate of ideas.

2. Create innovative ways in the organization to identify opportunities.

3. Consider the goals and objectives at the beginning of the project.

4. Consider the criteria to assess an opportunity.

5. Creatively think of ways to “unlock” value from an opportunity.

6. Undertake comparative analysis of the options.

7. Devise a general framework to review the opportunity but have an iterative approach to develop the framework as the project evolves.

For more information or to order a copy of the free white paper, please visit us at http://wescadiagroup.com/free-resources/white-paper/.

About Wescadia Group

Wescadia Group is a healthcare consultancy firm (http://wescadiagroup.com/services/consulting/) that works with healthcare organizations to help them achieve sustainable growth, bring innovative treatments to market and maximize the value of their assets. Our services are suitable for a range of healthcare organizations, including those in pharmaceutical & biotechnology, hospitals, clinical research, medical devices, diagnostics, research institutions as well as the government.

Contact:
Wescadia Group Pty Ltd (ABN 26.156.459.504)
Marcus Bain
Phone: +61. 8.8125.5820
Email: marcus.bain@wescadiagroup.com
Facebook: http://www.facebook.com/pages/Wescadia-Group-Pty-Ltd/282400431866944
Linkedin: http://www.linkedin.com/company/2649650
Twitter: https://twitter.com/wescadiagroup